FDA Approved: SOLIFENACIN SUCCINATE — Original Application (Apotex Corp.)

View source ↗

Summary

The FDA approved Apotex Corp.'s original ANDA for solifenacin succinate, a generic treatment for overactive bladder, providing a non-brand option.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Overactive Bladder

Drugs mentioned

• Solifenacin succinate (solifenacin)

Snippet

ORIG AP for SOLIFENACIN SUCCINATE (SOLIFENACIN SUCCINATE)